BHVN Valuation

Biohaven Ltd

Add to Watchlist

Advanced Chart

13.050

-0.45(-3.333%)1D

Overview
Forecast
Valuation
Earnings

BHVN Relative Valuation

BHVN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BHVN is overvalued; if below, it's undervalued.

Historical Valuation

Biohaven Ltd (BHVN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 241.21 is considered Undervalued compared with the five-year average of -4.57. The fair price of Biohaven Ltd (BHVN) is between 28.78 to 34.35 according to relative valuation methord. Compared to the current price of 13.49 USD , Biohaven Ltd is Undervalued By 53.12%.

Relative Value

Fair Zone

28.78-34.35

Current Price：13.49

53.12%

Undervalued

-1.85

Trailing

Forward

-1.59

EV/EBITDA

Biohaven Ltd. (BHVN) has a current EV/EBITDA of -1.59. The 5-year average EV/EBITDA is -3.67. The thresholds are as follows: Strongly Undervalued below -9.48, Undervalued between -9.48 and -6.58, Fairly Valued between -0.77 and -6.58, Overvalued between -0.77 and 2.14, and Strongly Overvalued above 2.14. The current Forward EV/EBITDA of -1.59 falls within the Historic Trend Line -Fairly Valued range.

-1.34

EV/EBIT

Biohaven Ltd. (BHVN) has a current EV/EBIT of -1.34. The 5-year average EV/EBIT is -3.97. The thresholds are as follows: Strongly Undervalued below -7.48, Undervalued between -7.48 and -5.72, Fairly Valued between -2.22 and -5.72, Overvalued between -2.22 and -0.47, and Strongly Overvalued above -0.47. The current Forward EV/EBIT of -1.34 falls within the Overvalued range.

241.21

Biohaven Ltd. (BHVN) has a current PS of 241.21. The 5-year average PS is 74140.57. The thresholds are as follows: Strongly Undervalued below -406128.27, Undervalued between -406128.27 and -165993.85, Fairly Valued between 314274.99 and -165993.85, Overvalued between 314274.99 and 554409.41, and Strongly Overvalued above 554409.41. The current Forward PS of 241.21 falls within the Historic Trend Line -Fairly Valued range.

-2.38

P/OCF

Biohaven Ltd. (BHVN) has a current P/OCF of -2.38. The 5-year average P/OCF is -6.11. The thresholds are as follows: Strongly Undervalued below -10.31, Undervalued between -10.31 and -8.21, Fairly Valued between -4.01 and -8.21, Overvalued between -4.01 and -1.91, and Strongly Overvalued above -1.91. The current Forward P/OCF of -2.38 falls within the Overvalued range.

-1.96

P/FCF

Biohaven Ltd. (BHVN) has a current P/FCF of -1.96. The 5-year average P/FCF is -7.68. The thresholds are as follows: Strongly Undervalued below -17.73, Undervalued between -17.73 and -12.70, Fairly Valued between -2.66 and -12.70, Overvalued between -2.66 and 2.37, and Strongly Overvalued above 2.37. The current Forward P/FCF of -1.96 falls within the Overvalued range.

Biohaven Ltd (BHVN) has a current Price-to-Book (P/B) ratio of 5.31. Compared to its 3-year average P/B ratio of 7.50 , the current P/B ratio is approximately -29.17% higher. Relative to its 5-year average P/B ratio of 7.50, the current P/B ratio is about -29.17% higher. Biohaven Ltd (BHVN) has a Forward Free Cash Flow (FCF) yield of approximately -47.08%. Compared to its 3-year average FCF yield of -19.80%, the current FCF yield is approximately 137.76% lower. Relative to its 5-year average FCF yield of -19.80% , the current FCF yield is about 137.76% lower.

5.31

P/B

Median3y

7.50

Median5y

7.50

-47.08

FCF Yield

Median3y

-19.80

Median5y

-19.80

Competitors Valuation Multiple

The average P/S ratio for BHVN's competitors is 1667.53, providing a benchmark for relative valuation. Biohaven Ltd Corp (BHVN) exhibits a P/S ratio of 241.21, which is -85.53% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Travere Therapeutics Inc

Viridian Therapeutics Inc

Performance Decomposition

Market capitalization of BHVN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of BHVN in the past 1 year is driven by Unknown.